交易 Aurinia Pharmaceuticals Inc. - AUPH 差價合約

交易條件

• 類型: 差價合約
• 點差: 0.11
• 長倉隔夜倉息調整: -0.02157%
• 短倉隔夜倉息調整: -0.00065%
• 隔夜倉息調整時間: 21:00 (UTC)
• 貨幣: USD
• 最低成交量: 1
• 保證金: 5.00%
• 證券交易所: United States of America
• 交易佣金: 0%
• 保證止損溢價: 1%

主要統計數據

• 前收盤價: 14.3
• 開倉: 14.37
• 1 年變化: 77.63%
• 日區間: 13.85 - 14.38

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. The company also offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.